최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biochemistry, v.35 no.28, 1996년, pp.9090 - 9096
Kraunsoe, J. A. E. , Claridge, T. D. W. , Lowe, G.
초록이 없습니다.
J. Magn. Reson. Bax A. 65 1985
Eur. J. Biochem. Beckmann J. 176 1988 10.1111/j.1432-1033.1988.tb14330.x
J. Mol. Biol. Berndt K. D. 227 1992 10.1016/0022-2836(92)90222-6
Eur. J. Biochem. Bode W. 204 1992 10.1111/j.1432-1033.1992.tb16654.x
Fibrinolysis 8, 161−171, and references cited therein Bode W. 1994
Biochemistry 28 Bode W. 1989
J. Magn. Reson. Braunschweiler L. 53 1983
Nature 298, 329−334 Carrell R. W. 1982
Biochem. Pharmacol. 24, 2177−2185 Cha S. 1975
Biochem. Biophys. Res. Commun. 29, 508−514 Chase T., Jr. 1967
J. Mol. Biol. Chen Z. 164 1983 10.1016/0022-2836(83)90078-5
Biotechnol. Appl. Biochem. 22, 269−280 Chesshyre J. A. 1995
Philos. Trans. R. Soc. London Courtney M. 317 1986
Science 256, 111−112 Creighton T. E. 1992
Drugs 49, 954−983 Davis R. 1995
Acta Crystallogr. Deisenhofer J. 31 1975 10.1107/S0567740875002415
Arzneim.-Forsch./Drug Res. 33(I), 479−494 Fritz H. 1983
J. Magn. Reson. Hoult D. I. 51 1983
J. Mol. Biol. Huber R. 101 89 1974 10.1016/0022-2836(74)90163-6
Methods Enzymol. 19, 844−852 Kassel B. 1970
Biochemistry 22, 3763−3770 Largman C. 1983
Ann. Rev. Biochem. Laskowski M., Jr. 49 1980
Arch. Biochem. Biophys. 190, 358−360 Lestienne P. 1978
J. Mol. Biol. Lobermann H. 177 1984
Biochemistry 32, 500−508 Lomas D. A. 1993
Biochemistry 29, 7339−7347 Longstaff C. 1990
J. Magn. Reson. Marion D. 79 1988
Biochemistry 19, 3973−3978 McRae B. 1980
Adv. Enzymol. Relat. Areas Mol. Biol. 61, 201−301 Morrison J. F. 1988
J. Biol. Chem. Nakajima K. 254 1979
J. Magn. Reson. Rance M. 74 1987
Mol. Phys. 68, 509−517 Rucker S. P. 1989
J. Mol. Biol. Schiffer C. A. 241 1994 10.1006/jmbi.1994.1533
Nature 225, 811−816 Shotton D. M. 1970
Nature 344, 685−688 Staley J. P. 1990
Thorax 48, 560−565 Tetley T. D. 1993
Ang. Chem., Int. Ed. Engl. Tschesche H. 28 13 1974 10.1002/anie.197400101
Drugs 29, 236−261 Verstraete M. 1985
Biochemistry 11, 2967−2977 Vincent J.-P. 1972
J. Mol. Biol. Wagner G. 196 1987
FEBS Lett. Wei A.-Z. 234 1988
J. Mol. Biol. Wlodawer A. 180 1984 10.1016/S0022-2836(84)80006-6
J. Mol. Biol. Wlodawer A. 198 1987 10.1016/0022-2836(87)90294-4
Biochemistry 32 Ying Q.-L. 1993
bovine pancreatic trypsin inhibitor Abbreviations BPTI
Minor changes are also observed at positions far removed from the sites of mutation, i.e., residues 25 and 49. These can be attributed to the variable N-terminal processing in the Aspergillus niger expression system which was used to prepare this mutant (Archer et al., unpublished work). This mutant was not available in sufficient quantity from E. coli (Chesshyre et al., 1995) for NMR spectroscopic investigation. Since the N-terminus is close to residues 25 and 49 in the tertiary structure of BPTI, it is not surprising that the additional N-terminal amino acid(s) perturb(s) the NH shifts of these residues. The additional residues were observed in the NMR spectrum, but since the major component was less than 40% of the total protein, their NH shifts have not been incorporated into Figure 4b.
N.B. For the binding of elafin to HLE, K i = 2.0 × 10 - 10 M but k on = 3.6 × 10 6 M - 1 s - 1 (Ying & Simon, 1993).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.